|
| INTRO EQUATIONS CRITERIA DECISION CONVERT SPECIALTIES REFS SEARCH NEW FHIR APP POLICIES CONTACT |
| International Prognostic Index for Non-Hodgkin Lymphoma |
The EBMcalc module International Prognostic Index for Non-Hodgkin Lymphoma is available in EBMcalc Complete Edition.
This calculator evaluates the following Clinical Criteria:
- Age >60 years old
- Serum lactate dehydrogenase concentartion above normal
- Ann Arbor stage III or IV
- More than one extranodal disease site
- ECOG performance scale
References
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993 Sep 30;329(14):987-94. PubMed ID: 8141877
- Ziepert M, Hasenclever D, Kuhnt E, et al. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. J Clin Oncol. 2010 May 10;28(14):2373-80. Epub 2010 Apr 12. Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779. PubMed ID: 20385988
- Oken MM, Creech RH, Tormey DC, et al., Eastern Cooperative Oncology Group, Robert Comis M.D., Group Chair. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5(6):649-55. PubMed ID: 7165009
Legal Notices and Disclaimer All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. EBMcalc is NOT a medical device. Click here for full notice and disclaimer. |